Strong Scientific and Clinical Evidence: 80+ publications скачать в хорошем качестве

Strong Scientific and Clinical Evidence: 80+ publications

Lipogems Microfragmented Fat™ is now supported by over 80 peer-reviewed publications with up to 3 year follow up data (95% are independent, investigator-initiated studies), a significant milestone for Lipogems™. Well respected institutions around the world have evaluated Lipogems Microfragmented Fat™ to characterize the quality of the tissue and application into clinical use in orthopaedics and other key specialties. The most recent publications have come from University of Pittsburgh, New York University, Harvard Spaulding/Mass General, Rutgers University, Kessler Foundation, University of Bologna, Galeazzi Orthopaedic Institute, St. Catherine Specialty Hospital, Negrar Hospital, Zealand University Hospital, and others. Lipogems now has over 6 years of clinical use and is available in 28 countries. Lipogems was pioneered by visionaries that understood the clinical challenges and limited resources of physicians to manage the needs of their patients that have tried conservative therapies with limited relief. Dr. Carlo Tremolada and Prof. Camillo Ricordi created an easy solution and the first FDA cleared technology that compliantly processes adipose tissue and preserves the high quality nature of the tissue. Leading physicians and institutions around the world have rapidly adopted the technology for patients that have tried conservative therapy and are not ready for major invasive surgery. “We are proud to be recognized as the most trusted adipose tissue technology and for the fact that physicians have come to depend on Lipogems clinically making us the leaders in this space ” said Carl Llewellyn, CEO of Lipogems USA. Physicians have adopted the Lipogems System for these top 5 reasons: 1. Trusted Option: High Physician Satisfaction for Patients in the Orthopaedic Treatment Gap (tried conservative therapies with limited relief and are not ready for major invasive surgery) 2. Compliant Solution: FDA cleared for use in orthopaedics and arthroscopic surgery and other specialties • 3 FDA clearances • Meets guidelines for minimal manipulation of the tissue (HCT/P 361 Guidance) • Intended for homologous use 3. Results Matter: Strong scientific and clinical evidence with more than 80 peer reviewed publications with up to 3 year follow up from trusted physicians and researchers • 95% are independent studies • One-time procedure for majority of patients 4. High Quality Tissue with Low Risks: Natural, minimally invasive option using the patient’s own adipose tissue • Adipose Tissue is high quality tissue that does not decline with age • Microfragmented Fat™ is high quality tissue with preserved cell and tissue microarchitecture that provides cushion and support of the healing process of damaged or injured tissue • Using the patient’s own tissue has minimal risk of rejection or infection 5. Economical and Efficient: • Comprehensive kit that creates a streamlined and efficient procedure that can be in the clinic, procedure room, or adjunct to surgery • Microfragmented Fat™ can be injected into multiple sites in the same setting “More than 80 peer reviewed publications with up to 3 year follow up is a milestone that we are proud of, especially since majority of the research has been conducted independently of the company. We are encouraged by the consistently positive results that have been reported across multiple indications. We thank all of the physicians and researchers that have worked so hard to contribute to evidence-based medicine to help patients have reliable and informed options.” said, Julie O’Connell, PhD, Lipogems Sr. Director of Scientific and Clinical Affairs. “Microfragmented Fat™ is here to stay in orthopaedics, coloprotocology, and other medical specialties, and at Lipogems we are committed to further advancing the scientific knowledge on this technology.”